OTHER GROUP COMPANIES
market

Lyka Labs launches two domestic marketing divisions

Lyka Labs Ltd has announced that Lyka Healthcare Limited, a wholly owned subsidiary of Lyka Labs Limited, has launched two domestic marketing divisions in the name of ENSPAN and CERABELLE. Enspan would be marketing Critical and Anesthesia range of Products and Cerabelle would be marketing Dermatology and Cosmetology range of Products.

April 11, 2016 2:18 IST | India Infoline News Service
Lyka Labs Ltd has announced that Lyka Healthcare Limited, a wholly owned subsidiary of Lyka Labs Limited, has launched two domestic marketing divisions in the name of ENSPAN and CERABELLE. Enspan would be marketing Critical and Anesthesia range of Products and Cerabelle would be marketing Dermatology and Cosmetology range of Products.
The above products would also be offered internationally in the 46 countries in which Lyka has its presence.

Lyka Labs Ltd is currently trading at Rs. 83.25, up by Rs. 0.55 or 0.67% from its previous closing of Rs. 82.7 on the BSE.
The scrip opened at Rs. 83.3 and has touched a high and low of Rs. 84.7 and Rs. 82 respectively. So far 74034(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 182.27 crore.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 142.9 on 26-Nov-2015 and a 52 week low of Rs. 50.25 on 28-Apr-2015. Last one week high and low of the scrip stood at Rs. 85.5 and Rs. 78.7 respectively.
The promoters holding in the company stood at 24.9 % while Institutions and Non-Institutions held 0.84 % and 74.27 % respectively.
The stock is currently trading above its 200 DMA.

Invest wise with Expert advice

FEATURED ARTICLE

BLOGS

Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp